Senior insider sale
BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$1.72M
25.48K shares
What this filing means
VALANTINE HANNAH plans to sell 25.48K shares of BRIDGEBIO PHARMA, INC. valued at approximately $1.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/27/2026ACC: 0001950047-26-001893
25.48K
Shares to sell
$1.72M
Approx. market value
25.48K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
2/27/2026
25.48KTotal acquired25.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/27/2026 | Stock Option Exercise Cash | 25.48K | — |
| Total | 25.48K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
25.48K
Market value
$1.72M
2/27/2026
Total
Units
25.48K
Value
$1.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/27/2026 | 25.48K | $1.72M | NASDAQ | Planned |
| Total | 25.48K | $1.72M | ||